Ads
related to: rifaximin generic name- Healthcare Professionals
Obtain Product Information
Relevant To Your Patients.
- Patient Stories
Hear From Real Patients Experience
With Xifaxan® (rifaximin).
- Resources & Support
Browse Our Resources & Information.
View The Doctor Discussion Guide.
- Learn More
Learn About Xifaxan® (rifaximin)
As A Treatment Option.
- Healthcare Professionals
Search results
Results From The WOW.Com Content Network
Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...
Lepetit filed for patent protection of Rifamycin B in the UK in August 1958, and in the US in March 1959. The British patent GB921045 was granted in March 1963, and U.S. Patent 3,150,046 was granted in September 1964. The drug is widely regarded as having helped conquer the issue of drug-resistant tuberculosis in the 1960s.
Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent ...
According to the drug’s manufacturer, 100% of Medicare Part D beneficiaries have some coverage for Xifaxan for either use. Medicare may also cover rifaximin (Xifaxan) for traveler’s diarrhea ...
This multi-page article lists pharmaceutical drugs alphabetically by name. Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales.
A common antibiotic used to treat liver disease could give rise to an “almost untreatable” superbug, scientists warned in a new study.. The antibiotic, rifaximin, has enabled the global ...
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International Nonproprietary Name
A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029.